Structure (Spironolactone 01)
Spironolactone Tablet
Product Images NDC 71205-772
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71205-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
Figure 2 (Spironolactone 03)
This appears to be a table showing different variables related to the subgroup of individuals with diabetes. The variables listed in the table include S Creatiine (ma/at), potassium levels, and whether or not individuals were taking beta blockers. It also appears to be comparing the use of Spironolactone vs. Placebo and indicating which one is better. Without more context or information it is difficult to provide a more specific description or interpretation.*
71205-772-30 (Spironolactone 04)
This is a description of Spironolactone 25mg tablets manufactured by Frontida BioPharm, Inc. and packaged by Proficient Rx LP. The tablets are white, round, unscored, and debossed with MP 35. Each bottle contains 30 tablets and has an NDC number of 71205-772-30. The lot number of the tablets is 00000, and the expiration date is 00/00/00. The tablets must be kept in a cool and dry place at a temperature of 20°-25°C (68°-77°F). This medication should be stored out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
